Literature DB >> 32213024

Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases.

Søren S Olesen1,2, Jakob L Poulsen1,2, Srdan Novovic3, Camilla Nøjgaard3, Evangelos Kalaitzakis4, Nanna M Jensen5, Trond Engjom6,7, Erling Tjora8,9, Anne Waage10, Truls Hauge11,12, Stephan L Haas13, Miroslav Vujasinovic13, Giedrius Barauskas14, Aldis Pukitis15, Imanta Ozola-Zālīte15, Alexey Okhlobystin16, Mikael Parhiala17,18, Johanna Laukkarinen17,18, Asbjørn M Drewes1,2.   

Abstract

BACKGROUND: Diabetes mellitus is a common complication of chronic pancreatitis. It is traditionally considered to develop as a consequence of beta cell loss, but there might be additional factors. Recent studies have highlighted the importance of type 2 diabetes-related risk factors in this context and population-based studies show increased risk of diabetes following acute pancreatitis. The aim of this study was to explore multiple risk factors for diabetes in patients with chronic pancreatitis.
METHODS: We conducted a multicentre, cross-sectional study of patients with definitive chronic pancreatitis according to the M-ANNHEIM criteria. We used multivariable logistic regression models to determine risk factors independently associated with diabetes.
RESULTS: The study included 1117 patients of whom 457 (40.9 %) had diabetes. The mean age was 52.8 ± 14.2 years and 67% were men. On multivariate analysis, parameters indicative of beta cell loss (pancreatic calcification, exocrine insufficiency, pancreatic resection) were confirmed as independent risk factors for diabetes (all p ≤ 0.02). In addition, type 2 diabetes-related risk factors (dyslipidaemia and overweight/obesity) were associated with the presence of diabetes (all p ≤ 0.002). Patients with a history of pancreatic fluid collections (indicative of previous attacks of acute pancreatitis) had a marginally increased risk of diabetes (p = 0.07).
CONCLUSION: In patients with chronic pancreatitis the presence of diabetes is associated with multiple risk factors including type 2 diabetes-related factors. Our observations attest to the understanding of this entity and may have implications for treatment.

Entities:  

Keywords:  Chronic pancreatitis; acute pancreatitis; diabetes mellitus; risk factors

Mesh:

Year:  2020        PMID: 32213024      PMCID: PMC7226693          DOI: 10.1177/2050640620901973

Source DB:  PubMed          Journal:  United European Gastroenterol J        ISSN: 2050-6406            Impact factor:   4.623


  30 in total

1.  Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk Factors.

Authors:  Søren S Olesen; Camilla Nøjgaard; Jakob L Poulsen; Stephan L Haas; Miroslav Vujasinovic; Matthias Löhr; Björn Lindkvist; Louise Bexander; Antanas Gulbinas; Evangelos Kalaitzakis; Mohamed Ebrahim; Friedemann Erchinger; Trond Engjom; Stine Roug; Srdan Novovic; Truls Hauge; Anne Waage; Johanna Laukkarinen; Mikael Parhiala; Aldis Pukitis; Imanta Ozola-Zālīte; Asbjørn M Drewes
Journal:  Am J Gastroenterol       Date:  2019-04       Impact factor: 10.864

2.  Complications to Chronic Pancreatitis and Etiological Risk Factors: A Continental Divide?

Authors:  Søren S Olesen; Asbjørn M Drewes
Journal:  Am J Gastroenterol       Date:  2019-08       Impact factor: 10.864

3.  The sentinel acute pancreatitis event hypothesis revisited.

Authors:  Søren Schou Olesen; Asbjørn Mohr Drewes; Srdan Novovic; Camilla Nøjgaard
Journal:  Pancreatology       Date:  2019-04-03       Impact factor: 3.996

4.  Pancreatic calcifications associate with diverse aetiological risk factors in patients with chronic pancreatitis: A multicentre study of 1500 cases.

Authors:  Søren S Olesen; Maria Valeryevna Lisitskaya; Asbjørn M Drewes; Srdan Novovic; Camilla Nøjgaard; Evangelos Kalaitzakis; Nanna M Jensen; Trond Engjom; Friedemann Erchinger; Anne Waage; Truls Hauge; Stephan L Haas; Miroslav Vujasinovic; Björn Lindkvist; Kristina Zviniene; Aldis Pukitis; Imanta Ozola-Zālīte; Alexey Okhlobystin; Mikael Parhiala; Johanna Laukkarinen; Jens B Frøkjær
Journal:  Pancreatology       Date:  2019-08-21       Impact factor: 3.996

Review 5.  Precision medicine in the management of type 2 diabetes.

Authors:  Anna L Gloyn; Daniel J Drucker
Journal:  Lancet Diabetes Endocrinol       Date:  2018-04-23       Impact factor: 32.069

6.  The Scandinavian baltic pancreatic club (SBPC) database: design, rationale and characterisation of the study cohort.

Authors:  Søren S Olesen; Jakob L Poulsen; Asbjørn M Drewes; Jens B Frøkjær; Johanna Laukkarinen; Mikael Parhiala; Iben Rix; Srdan Novovic; Björn Lindkvist; Louise Bexander; Georg Dimcevski; Trond Engjom; Friedemann Erchinger; Ingfrid S Haldorsen; Aldis Pukitis; Imanta Ozola-Zālīte; Stephan Haas; Miroslav Vujasinovic; J Matthias Löhr; Antanas Gulbinas; Nanna M Jensen; Maiken T Jørgensen; Camilla Nøjgaard
Journal:  Scand J Gastroenterol       Date:  2017-05-04       Impact factor: 2.423

Review 7.  Mechanisms and emerging treatments of the metabolic complications of chronic pancreatitis.

Authors:  Dana K Andersen
Journal:  Pancreas       Date:  2007-07       Impact factor: 3.327

8.  Fasting Blood Glucose Levels Provide Estimate of Duration and Progression of Pancreatic Cancer Before Diagnosis.

Authors:  Ayush Sharma; Thomas C Smyrk; Michael J Levy; Mark A Topazian; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-04-30       Impact factor: 22.682

Review 9.  Newly diagnosed diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis.

Authors:  Stephanie L M Das; Primal P Singh; Anthony R J Phillips; Rinki Murphy; John A Windsor; Maxim S Petrov
Journal:  Gut       Date:  2013-08-08       Impact factor: 23.059

10.  Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes.

Authors:  Ayush Sharma; Harika Kandlakunta; Sajan Jiv Singh Nagpal; Ziding Feng; William Hoos; Gloria M Petersen; Suresh T Chari
Journal:  Gastroenterology       Date:  2018-06-11       Impact factor: 22.682

View more
  7 in total

1.  Pancreatogenic diabetes, acute pancreatitis management, and pancreatic tuberculosis: Appraising the present and setting goals for the future.

Authors:  Jorge D Machicado; Georgios I Papachristou
Journal:  United European Gastroenterol J       Date:  2020-05       Impact factor: 4.623

Review 2.  The spectrum of diabetes in acute and chronic pancreatitis.

Authors:  Søren S Olesen; Frederico G S Toledo; Phil A Hart
Journal:  Curr Opin Gastroenterol       Date:  2022-07-18       Impact factor: 2.741

Review 3.  The Impact of Pancreatic Exocrine Diseases on the β-Cell and Glucose Metabolism-A Review with Currently Available Evidence.

Authors:  Marina Ciochina; Daniel Vasile Balaban; George Manucu; Mariana Jinga; Cristian Gheorghe
Journal:  Biomolecules       Date:  2022-04-21

4.  Structural imaging findings are related to clinical complications in chronic pancreatitis.

Authors:  Ingrid Kvåle Nordaas; Erling Tjora; Georg Dimcevski; Ingfrid S Haldorsen; Søren Schou Olesen; Asbjørn Mohr Drewes; Kristina Zviniene; Giedrius Barauskas; Berivan Kyed Bayram; Peter Nørregaard; Anders Borch; Camilla Nøjgaard; Annette Bøjer Jensen; Svetlana S Kardasheva; Alexey Okhlobystin; Truls Hauge; Anne Waage; Jens Brøndum Frøkjaer; Trond Engjom
Journal:  United European Gastroenterol J       Date:  2022-04-09       Impact factor: 6.866

5.  Complications of chronic pancreatitis prior to and following surgical treatment: A proposal for classification.

Authors:  Marko Murruste; Ülle Kirsimägi; Karri Kase; Tatjana Veršinina; Peep Talving; Urmas Lepner
Journal:  World J Clin Cases       Date:  2022-08-06       Impact factor: 1.534

Review 6.  Diabetes in chronic pancreatitis: risk factors and natural history.

Authors:  Mark O Goodarzi; Maxim S Petrov; Dana K Andersen; Phil A Hart
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

Review 7.  Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus.

Authors:  Phil A Hart; Dana K Andersen; Maxim S Petrov; Mark O Goodarzi
Journal:  Curr Opin Gastroenterol       Date:  2021-09-01       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.